Paradise J L
Ambulatory Care Center, Children's Hospital of Pittsburgh, PA 15213-3417.
Ann Otol Rhinol Laryngol Suppl. 1992 Jan;155:33-6. doi: 10.1177/00034894921010s107.
Antimicrobial prophylaxis for recurrent otitis media was first reported in 1960 in an uncontrolled study using a long-acting sulfonamide in Native American children younger than 11 years of age. In subsequent controlled studies using various antimicrobial drugs (primarily aminopenicillins or sulfonamides) subjects receiving prophylaxis continued to have episodes of acute otitis media, but at rates substantially lower than those of controls. More recently, prophylaxis has appeared effective in reducing the number of acute recurrences, but not the cumulative proportion of time with middle ear effusion that was present independent of such recurrences. Although questions remain about choice of drug, optimal dosage schedules, risk of untoward drug reactions, duration of use, and the risk of encouraging the emergence of resistant strains of pathogenic bacteria, antimicrobial prophylaxis currently appears to be the most logical first approach in the management of the child with recurrent otitis media.
复发性中耳炎的抗菌预防首次报道于1960年,是一项针对11岁以下美国原住民儿童使用长效磺胺类药物的非对照研究。在随后使用各种抗菌药物(主要是氨基青霉素或磺胺类药物)的对照研究中,接受预防治疗的受试者仍会出现急性中耳炎发作,但其发生率远低于对照组。最近,预防措施似乎在减少急性复发次数方面有效,但对于与这些复发无关的中耳积液持续时间的累积比例并无效果。尽管在药物选择、最佳给药方案、药物不良反应风险、使用持续时间以及促使病原菌耐药菌株出现的风险等方面仍存在疑问,但抗菌预防目前似乎是治疗复发性中耳炎儿童最合理的首选方法。